Simon GE, Unutzer J: Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 1999, 50 (10): 1303-1308.
Article
CAS
PubMed
Google Scholar
Stender M, Bryant-Comstock L, Phillips S: Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis. Clin Ther. 2002, 24 (10): 1668-1676. 10.1016/S0149-2918(02)80070-4.
Article
PubMed
Google Scholar
Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM: The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994, 31 (4): 281-294. 10.1016/0165-0327(94)90104-X.
Article
CAS
PubMed
Google Scholar
Li J, McCombs JS, Stimmel GL: Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord. 2002, 71 (1-3): 131-139. 10.1016/S0165-0327(01)00394-9.
Article
PubMed
Google Scholar
Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA: Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry. 2002, 159 (6): 1005-1010. 10.1176/appi.ajp.159.6.1005.
Article
PubMed
Google Scholar
Guo JJ, Keck PE, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ: Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study. J Clin Psychiatry. 2006, 67 (7): 1055-1061. 10.4088/JCP.v67n0707.
Article
CAS
PubMed
Google Scholar
APA: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002, 159 (4 Suppl): 1-50.
Google Scholar
Goodwin GM: Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003, 17 (2): 149-173. 10.1177/0269881103017002003. discussion 147
Article
CAS
PubMed
Google Scholar
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Moller HJ, Disorders WTFoTGfB: The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry. 2003, 4 (1): 5-13. 10.3109/15622970309167904.
Article
PubMed
Google Scholar
Yatham LN: Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am. 2005, 28 (2): 325-347. 10.1016/j.psc.2005.01.001.
Article
PubMed
Google Scholar
Suppes T, Dennehy EB, Hirschfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC: The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005, 66 (7): 870-886. 10.4088/JCP.v66n0710.
Article
PubMed
Google Scholar
Guo JJ, Keck PE, Li H, Jang R, Kelton CM: Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population. Value Health. 2008, 11 (3): 416-423. 10.1111/j.1524-4733.2007.00287.x.
Article
PubMed
Google Scholar
Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G: Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Clin Ther. 2009, 31 (4): 836-848. 10.1016/j.clinthera.2009.04.022.
Article
PubMed
Google Scholar
Jing Y, Kim E, You M, Pikalov A, Tran QV: Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. J Med Econom. 2009, 12 (2): 104-113. 10.3111/13696990903044092.
Article
Google Scholar
Glynn RJ, Schneeweiss S, Sturmer T: Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006, 98 (3): 253-259. 10.1111/j.1742-7843.2006.pto_293.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45 (6): 613-619. 10.1016/0895-4356(92)90133-8.
Article
CAS
PubMed
Google Scholar
Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY: Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999, 20: 125-144. 10.1146/annurev.publhealth.20.1.125.
Article
CAS
PubMed
Google Scholar
Manning WG, Basu A, Mullahy J: Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005, 24 (3): 465-488. 10.1016/j.jhealeco.2004.09.011.
Article
PubMed
Google Scholar
Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH: The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder. Int Clin Psychopharmacol. 2008, 23 (6): 305-316. 10.1097/YIC.0b013e32830b0f88.
Article
PubMed
Google Scholar
Citrome L, Reist C, Palmer L, Montejano L, Lenhart G, Cuffel B, Harnett J, Sanders KN: Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schizophr Res. 2009, 108 (1-3): 238-244. 10.1016/j.schres.2008.11.017.
Article
PubMed
Google Scholar
Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH: Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. J Clin Psychiatry. 2006, 67 (2): 222-232. 10.4088/JCP.v67n0208.
Article
CAS
PubMed
Google Scholar
Wang Z, Salmon JW, Walton SM: Cost-effectiveness analysis and the formulary decision-making process. J Manag Care Pharm. 2004, 10 (1): 48-59.
PubMed
Google Scholar
Pearl J: Causality: Models, Reasoning and Inference. 2009, Cambridge University Press, 2
Book
Google Scholar
Heckman : Econometric causality. National Bureau of Economic Research Working paper 13934. 2008
Google Scholar